memantine.com - Memantine in moderate-to-severe Alzheimer's Disease
The memantine-treated patients showed significantly less decline in cognitive ... that "the tolerability of memantine in this study was found to be excellent. ...
memantine.com - Memantine in moderate-to-severe Alzheimer's Disease
Memantine in moderate-to-severe Alzheimer's disease ... Memantine is now available in the USA. For more information, please visit www.namenda.com ...
Memantine - Wikipedia, the free encyclopedia
Although memantine is approved for treatment of moderate to severe Alzheimer's ... Memantine has been associated with a moderate decrease in clinical deterioration ...
Memantine in Moderate-to-Severe Alzheimer's Disease -- Research article ...
This New England Journal of Medicine study concludes antiglutamatergic treatment with memantine, an NMDA antagonist, reduced clinical deterioration in moderate-to ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... In a study of 28 weeks duration, 252 patients with moderate to severe probable ...
030403 Memantine in Moderate-to-Severe Alzheimer's Disease
memantine in outpatients with moderate-to-severe. Alzheimer's disease. p a t i e n t s ... adverse events were mild to moderate in severity ...
memantine (Namenda) - drug class, medical uses, medication side effects ...
Specifies the medication memantine (Namenda), a drug used for the treatment of moderate to severe dementia of the Alzheimer's type.
Memantine in Moderate-to-severe Alzheimer's Disease | Neurology
... of dementia. It is a progressive neurodegenerative disorder resulting in cognitive and behavioural impairment of ... Disease > Memantine in Moderate-to ...
Memantine
... R, Stoffler A, et al, "Memantine in Moderate-to-Severe Alzheimer's Disease,"N ... Farlow MR, Grossberg GT, et al, "Memantine Treatment in Patients With Moderate ...
CNSforum | Memantine in moderate-to-severe Alzheimer's disease
... treatment of Alzheimer's disease (AD) in moderate-to-severe stages. ... Memantine/donepezil dual therapy is superior to placebo/donepezil therapy for ...
|
Memantine Appears Effective And Safe In Moderate To Severe Alzheimer's Disease Memantine, a drug approved for the treatment of Alzheimer disease, appears safe and effective in patients with moderate to severe cases of the condition, according to a study in the January issue of Archives of Neurology, one of the JAMA/Archives journals. Millions of people worldwide have Alzheimer disease (AD), a progressive neurodegenerative disorder, according to background information in the article. Various chemical and other processes in the brain may contribute to the development of the condition. Memantine appears to act on one of those pathways, which involves the neurotransmitter glutamate, the authors report. The drug was approved in the United States in 2003 and also is available in the European Union and Australia.